Suchergebnisse - "Neil, Garry A."

PubPharm (6)

1

Method of treating acute respiratory distress syndrome (ARDS) or acute lung injury (ALI) associate with COVID-19 by administering an anti-LIGHT antibody

enthalten in: Europäisches Patentamt | 2023

von NEIL GARRY A | ZAFIR-LAVIE INBAL

2

Method of treating acute respiratory distress syndrome (ARDS) or acute lung injury (ALI) associate with COVID-19 by administering an anti-LIGHT antibody

enthalten in: Europäisches Patentamt | 2023

von NEIL GARRY A | ZAFIR-LAVIE INBAL

3

Levels of the TNF related cytokine, LIGHT increase in hospitalized COVID-19 patients with Cytokine Release Syndrome and ARDS

enthalten in: bioRxiv.org | 2022

von Perlin, D. | Zafir-Lavie, I. | Roadcap, L. | +3

4

Randomized, double-blind, controlled trial of human anti-LIGHT monoclonal antibody in COVID-19 acute respiratory distress syndrome

enthalten in: The Journal of clinical investigation | 2022

von Perlin, D. | Neil, G. | Anderson, C. | +4

5

CERC-002, a human anti-LIGHT mAb reduces respiratory failure and death in hospitalized COVID-19 ARDS patients

enthalten in: bioRxiv.org | 2021

von Perlin, D. | Neil, G. | Anderson, C. | +5

6

Levels of the TNF-Related Cytokine LIGHT Increase in Hospitalized COVID-19 Patients with Cytokine Release Syndrome and ARDS

enthalten in: mSphere | 2020

von Perlin, D. | Zafir-Lavie, I. | Roadcap, L. | +3

1
[1]